Dr. Deepa Danan, MD

Dr. Danan practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.

Dr. Danan's NPI, 1295024339, was assigned on March 29, 2011. Dr. Danan graduated from Vagelos College of Physicians and Surgeons in 2011. Dr. Danan holds Florida license ME127503.

Dr. Danan's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.

Dr. Danan's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Dr. Danan is also affiliated with Moffitt Cancer Hospital. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Danan to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Danan practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Danan's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Danan is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Danan's licenses on file in 2 states: Florida and Virginia.

Dmand AI lists thyroid surgery among the conditions Dr. Danan treats.

CMS data shows 179 Medicare services from Dr. Danan across 6 procedure codes in 2024, for 101 Medicare patients. Medicare paid $28,626 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 101 Medicare patients who saw Dr. Danan in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Danan's median patient age at 69, with 42% women.

In 2024, Dr. Danan wrote 41 Medicare Part D claims for 27 patients. 95% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $101 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Danan for performance year 2024, reported as part of a group. Dr. Danan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Danan as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 29 papers to Dr. Danan, published from 2010 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Carcinoma, Squamous Cell, Free Tissue Flaps and Head and Neck Neoplasms. Dr. Danan has published most often in Head Neck. Dr. Danan's most frequent co-authors are Peter T. Dziegielewski, MD, David C. Shonka, MD and Brian Bishop Hughley, MD.

CMS Open Payments shows 28 general payments to Dr. Danan from 6 drug and device companies from 2016 to 2024. Education make up the largest share, 53% of the total. Intuitive Surgical, Inc. paid the most, $4,698.

Dr. Danan graduated from Vagelos College of Physicians and Surgeons in 2011.

Dr. Danan is in network with 8 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.